Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Business Insurance: Reviews of psych claims in comp increase
Requests for independent medical examinations for workers compensation claims with a psychological condition are rising, in part due to great
WorkCompWire
Article
Five Initial Evaluation Issues That May Delay Return to Work
By Mariellen Blue, National Director of Case Management at Genex Services
Mitchell
News Release
Mitchell Announces Launch of Intelligent Estimating Solution
SAN DIEGO, CA—Mitchell International, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Blog
High Impact Drug Class Trends in 2018
Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionate
Mitchell
Article
Five Questions with Assured Research President William Wilt on What’s Trending in Auto and Workers’ Comp Today
We sat down with William Wilt, president of P&C industry research firm
Mitchell
News Release
Congress Makes Moves to Weed Out Marijuana Restrictions
After considering several marijuana-related bills, the US House passed HR 1595, the SAFE Banking Act on Wednesday, September 25, 2019.